
Alpha Teknova (TKNO) Stock Forecast & Price Target
Alpha Teknova (TKNO) Analyst Ratings
Bulls say
Alpha Teknova Inc has demonstrated significant financial strength, as evidenced by a sequential gross margin increase of 680 basis points, reflecting the operational leverage in its business model. The company has successfully expanded its Lab Essentials customer base, rising from 2,829 at the end of 2023 to 2,913 year-to-date, indicating robust demand and customer engagement. Additionally, Alpha Teknova's confidence in achieving its fiscal year 2024 revenue guidance is bolstered by improved market conditions, enhanced manufacturing efficiency, and strong performance in both clinical and operational segments.
Bears say
Alpha Teknova Inc. is facing a challenging financial outlook due to anticipated declines in Clinical Solutions revenue for 2024, despite an increase in customer count. The company's planned investments in manufacturing, sales, and R&D are expected to lead to operating losses in the near term, with recent performance indicating higher general and administrative expenses than initially estimated. Additionally, potential issues with acquisitions and compliance with debt covenants pose risks that could further impact profitability and core operations.
This aggregate rating is based on analysts' research of Alpha Teknova and is not a guaranteed prediction by Public.com or investment advice.
Alpha Teknova (TKNO) Analyst Forecast & Price Prediction
Start investing in Alpha Teknova (TKNO)
Order type
Buy in
Order amount
Est. shares
0 shares